On August 19, 2025, iBio, Inc. announced an agreement to sell pre-funded warrants to purchase 71,540,000 shares for approximately $50 million, with potential for additional funds from warrant exercises. This event is classified under 'Changes in capital structure' and is significant for investors, carrying a positive sentiment.